Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by WEIGLE, K. A
Right arrow Articles by ROJAS, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WEIGLE, K. A
Right arrow Articles by ROJAS, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

research-article

A Clinical Prediction Rule for American Cutaneous Leishmaniasis in Colombia

KRISTEN A WEIGLE*, MIGUEL ESCOBAR{dagger}, ALBA LUCIA ARIAS{dagger}, FERNANDO MARTINEZ{dagger} and CARLOS ROJAS{dagger}

* Campus Box 7400, Department of Epidemiology, School of Public Health, University of North Carolina Chapel Hill, NC 27599-7400, USA
{dagger} Fundacion Centro Internacional de Investigaciones Medicas CIDEIM, Cali, Colombia

Neither parasitological nor molecular diagnosis of leishmaniasis is widely available in clinical settings where American cutaneous leishmaniasis (ACL) is endemic. Therefore four clinical prediction rules for ACL were developed which in corporated physical examination findings (clinical rule), physical examination and lelshrnanin skin test (LST) (clinical LST rule), physical examination and historical information (clinical-historical rule), or physical examination, historical information and LST (clinical-histoncal-LST rule). One hundred parasitologically diagnosed ACL cases and 38 cases of chronic skin lesions of other aetiologies comprised the derivation set. The validation set consisted of 124 ACL cases and 35 patients with lesions of other aetiologies. Components of each rule were selected by bivanate analysis, then stepwise logistic regression. Sensitivity, specificity and efficiency were calculated for each score threshold; the threshold achieving greatest efficiency was selected for each rule. When these rules were applied to the validity set the sensitivity, specificity and efficiency were respectively: clinical 93%, 31%, 79%; cllnical-LST 90%, 73%, 85.9%; clinical-historical 97%, 51%, 87%; clinical-historical-LST 92%, 70%, 87%. Inclusion of LST skin test consistently improved the specificity of the rules. Should a given clinical setting warrant optimizing either sensitivity or specificity alone, the rule thresholds can be adjusted. These and other prediction rules, once evaluated in other settings, should be in corporated into leishmaniasis control programmes.

Received 1 September 1992


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
C. Marin, S. S. Longoni, J. Urbano, G. Minaya, H. Mateo, J. A. de Diego, M. J. Rosales, G. Perez-Cordon, D. Romero, and M. Sanchez-Moreno
Enzyme-linked Immunosorbent Assay for Superoxide Dismutase-Excreted Antigen in Diagnosis of Sylvatic and Andean Cutaneous Leishmaniasis of Peru
Am J Trop Med Hyg, January 1, 2009; 80(1): 55 - 60.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.